510(k) K012287
K012287 is an FDA 510(k) premarket notification submitted by Roche Diagnostics Corp. for the device "MODIFICATION TO: COBAS INTEGRA LDL-CHOLESTEROL PLUS 2ND GENERATION". The FDA issued a decision of Substantially Equivalent on Aug 7, 2001. The device falls under product code MRR (System, Test, Low Density, Lipoprotein), a Class I device regulated under 21 CFR 862.1475. Roche Diagnostics Corp. has 456 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 7, 2001
- Date Received
- Jul 20, 2001
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- System, Test, Low Density, Lipoprotein
- Device Class
- Class I
- Regulation Number
- 862.1475
- Review Panel
- CH
- Submission Type
- 510(k) Exempt
Need the full FDA record for Roche Diagnostics Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.